Applied DNA Sciences Stock Scheduled to Reverse Split on Thursday, April 25th (NASDAQ:APDN)

Applied DNA Sciences, Inc. (NASDAQ:APDN) shares are going to reverse split on Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 25th.

Applied DNA Sciences Stock Performance

Shares of Applied DNA Sciences stock traded down $0.04 during midday trading on Tuesday, reaching $0.29. 811,420 shares of the company’s stock traded hands, compared to its average volume of 116,854. The company has a market cap of $4.92 million, a price-to-earnings ratio of -0.54 and a beta of 0.07. The company’s 50 day simple moving average is $0.49 and its 200 day simple moving average is $0.67. Applied DNA Sciences has a 52 week low of $0.28 and a 52 week high of $1.86.

Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings results on Thursday, February 8th. The technology company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.22. The business had revenue of $0.89 million for the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. As a group, equities research analysts predict that Applied DNA Sciences will post -0.63 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on APDN. StockNews.com began coverage on shares of Applied DNA Sciences in a research report on Sunday. They set a “hold” rating on the stock. HC Wainwright cut their price target on shares of Applied DNA Sciences from $2.00 to $1.50 and set a “buy” rating for the company in a report on Friday, February 9th.

Institutional Investors Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences as of its most recent filing with the Securities & Exchange Commission. 22.22% of the stock is currently owned by institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.